* RBI restricts Paytm Payments Bank from fresh deposits and credit transactions.
* Sun Pharma Q3 results Net profit up 16.5% at Rs 2,524 cr on US, India biz.
* Dabur to invest Rs 135 cr for a new manufacturing facility in south India.
* Centre slashes import duty on mobile phone components from 15% to 10%.
* Japan's Mizuho finance group sets up a global business center in Chennai.
* Gold price climbs Rs 220 to Rs 63,270, silver rises Rs 300 to Rs 76,500.
* Centre releases advisories, and surveys to boost female workforce participation.
* Govt appoints 3 full-time, 1 part-time member of 16th Finance Commission.
* Swiggy revenue jumps 45% to Rs 8,625 cr in FY23, loss widens to Rs 4,179 cr.
* US-based Fidelity cuts SoftBank-backed Meesho's valuation to $3.5 bn.
* Tata Group, Texas Instruments among bidders for SCL Mohali revamp Report.
* Suzlon Q3 Results: Cons PAT rises 2.6x YoY to Rs 203 crore, debt reduces further.
* Dutch watchdog fines Uber 10 million euro over privacy regulations infringement.
* NPST revenues surge 210% in Q3, approves 1:2 bonus issue.
* IndiGo wins the ch-aviation award for 'World's Youngest Aircraft Fleet' for the second year running.
* Max Healthcare Institute Q3 Results: Net profit rises 26% YoY to Rs 338 crore.
* India’s gold consumption in 2023 dropped by 3%: WGC.
* Mercedes-Benz sets eyes on smaller cities to fuel further growth.
* Ethereum ETF approval expected in May, predicts Standard Chartered.
* Global gold demand at an all-time high in 2023 backed by central bank purchases.
* TikTok owner ByteDance's chief warns against mediocrity as AI brings disruption.
* GM to cut spending by $1 billion on robotaxi unit Cruise in 2024.
* India's April-December fiscal deficit at ₹9.82 lakh crore, 55% of FY24 target.
* Dabur Q3 results: Net profit up 8% at ₹514.2 crore.
* Bank of Baroda Q3 results: Net profit rises 19% to ₹4,579 crore.
* Maruti Suzuki Q3 net profit jumps 33% to ₹3,130 crore, revenue grows 15% YoY.
* Ambuja Cements Q3 net profit rises 39% to ₹513.7 crore; revenue up 7.5% YoY.
* Sun Pharma Q3 results: Net profit up 16.5% at ₹2,524 crore.
* JSPL Q3 results: Net profit at ₹2,524 crore, operating margin at 24.3%.
* Infosys collaborates with Ireland’s Musgrave to drive cognitive-first IT transformation.
* PVR Inox capex on track, focus on south India markets.
* Pharmeasy FY23 losses widen 31%, revenue increases 16% to Rs 6,644 cr.
* mobilizesADB mobilises Rs 1,250 cr through the issuance of green bonds in the local market.
0 Comments